Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Liver Cancer

Fig.1 Liver cancer

Liver cancer, also named as primary hepatic cancer and hepatic cancer and is the cancer that originates in the liver. Primary liver cancer is the second leading cause of death from cancer (9%) and sixth most frequent cancer (6%) worldwide. Many cancers found in the liver are not really liver cancers, but are cancers from other parts in the body that have spread to the liver (also known as metastases). Cholangiocarcinoma is associated with weight loss, jaundice, sweating, abdominal pain and liver enlargement. And hepatocellular carcinoma is associated with weight loss, abdominal mass, abdominal pain, fever, emesis, anemia, back pain, jaundice and itching. Viral infection with either Hepatitis B virus (HBV) or hepatitis C virus (HCV) is the chief cause of liver cancer globally today, making up 80% of hepatocellular carcinoma (HCC). High levels of alpha-fetoprotein (AFP) in the blood can be found in many cases of intrahepatic cholangiocarcinoma and HCC.